Results 191 to 200 of about 27,085 (217)
Some of the next articles are maybe not open access.
Human receptor for C3b/C4b: Complement receptor type I
1987Publisher Summary Receptor function and protein are shown to reside on cells of the myelomonocytic series, mature B lymphocytes, glomerular podocytes, a small population of T lymphocytes, follicular dendritic cells, and even in plasma. The purification scheme to be described in the chapter has made available amounts of purified CR1 sufficient for ...
W W, Wong, D T, Fearon
openaire +2 more sources
Gastroenterology, 1990
The epithelial destruction seen in ulcerative colitis remains unexplained. Complement activation has been proposed to be involved, but no definite evidence has been available to this end. In the present study, we examined immunohistochemically ulcerative colitis lesions with monoclonal antibodies to activation neoepitopes in the complement component ...
T S, Halstensen +4 more
openaire +2 more sources
The epithelial destruction seen in ulcerative colitis remains unexplained. Complement activation has been proposed to be involved, but no definite evidence has been available to this end. In the present study, we examined immunohistochemically ulcerative colitis lesions with monoclonal antibodies to activation neoepitopes in the complement component ...
T S, Halstensen +4 more
openaire +2 more sources
The Journal of experimental medicine, 1973
IN THE PRESENT STUDY IT WAS SHOWN THAT NORMAL PERIPHERAL LYMPHOCYTES HAVE TWO DIFFERENT COMPLEMENT RECEPTORS: one for C3b (the immune adherence receptor) and one for C3b subsequent to its cleavage by C3b inactivator. The two receptors are not cross-reactive and were shown by tests with various antisera to be antigenically distinct.
G D, Ross +3 more
openaire +1 more source
IN THE PRESENT STUDY IT WAS SHOWN THAT NORMAL PERIPHERAL LYMPHOCYTES HAVE TWO DIFFERENT COMPLEMENT RECEPTORS: one for C3b (the immune adherence receptor) and one for C3b subsequent to its cleavage by C3b inactivator. The two receptors are not cross-reactive and were shown by tests with various antisera to be antigenically distinct.
G D, Ross +3 more
openaire +1 more source
Blood, 2003
AbstractWe investigated deposition of the complement protein fragment C3b and its breakdown products (collectively designated as C3b(i)) on CD20-positive cells treated with rituximab (RTX) in the presence of normal human serum (NHS). Radioimmunoassay (RIA) demonstrates that about 500 000 C3b(i) molecules deposit per cell, and fluorescence microscopy ...
Adam D, Kennedy +7 more
openaire +2 more sources
AbstractWe investigated deposition of the complement protein fragment C3b and its breakdown products (collectively designated as C3b(i)) on CD20-positive cells treated with rituximab (RTX) in the presence of normal human serum (NHS). Radioimmunoassay (RIA) demonstrates that about 500 000 C3b(i) molecules deposit per cell, and fluorescence microscopy ...
Adam D, Kennedy +7 more
openaire +2 more sources
Structure of complement component C3b
Molecular Immunology, 2007Bert J.C. Janssen +4 more
openaire +1 more source
Purification and crystallization of Complement C3b
Protocol Exchange, 2006Abdul Ajees Abdul Salam +5 more
openaire +1 more source
Complement C3b fixation in lupus erthematosus
Molecular Immunology, 1982U. Huschka, P.K. Kohl, E.W. Rauterberg
openaire +1 more source
[Erythrocyte complement receptor (C3b) expression in multiple sclerosis].
Neurologia i neurochirurgia polska, 1991The study was carried out in 121 patients with multiple sclerosis and a control group of 519 healthy individuals. In 13 cases of multiple sclerosis and 12 controls family studies were carried out. Complement receptors (C3bR) on the erythrocytes were demonstrated by the haemagglutination test using human IgG heat-aggregated and guinea pig serum which ...
J, Nowak, M, Wender
openaire +1 more source
Characterization of the interactions between C3b and complement regulators
Molecular Immunology, 2010Jin Wu +6 more
openaire +1 more source

